Pellegrino Joseph P JR 4
4 · LEMAITRE VASCULAR INC · Filed Apr 23, 2026
Research Summary
AI-generated summary of this filing
Lemaitre Vascular (LMAT) Director Joseph Pellegrino Exercises Options
What Happened
- Joseph P. Pellegrino Jr., a director of Lemaitre Vascular, exercised stock options on April 22, 2026. The exercise resulted in acquisition of 2,941 shares at an exercise price of $35.48 per share, a total cash cost of $104,347.
- The filing also reports the related derivative conversion at $0.00, which reflects the conversion/surrender of the option instrument into the underlying shares (see footnotes).
Key Details
- Transaction date: 2026-04-22; Form 4 filed: 2026-04-23 (timely).
- Transaction type/code: M (exercise/conversion of derivative).
- Shares acquired: 2,941 at $35.48 each; total cash paid $104,347.
- Derivative conversion reported: 2,941 shares @ $0.00 (represents the option conversion into shares) — Footnote F1.
- Footnote F2: the option was fully vested and exercisable at time of exercise.
- Shares owned after the transaction: not specified in the provided filing excerpts.
Context
- This was an exercise of vested options (not an open-market purchase or a sale). No immediate sale of the acquired shares is reported in the filing, so this appears to be an exercise for ownership rather than a cashless exercise/sale.
- Transaction code M denotes option exercise; the $0.00 line is a common way to report conversion of a derivative instrument into the underlying shares and does not indicate a sale.
Insider Transaction Report
Form 4
Pellegrino Joseph P JR
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-04-22$35.48/sh+2,941$104,347→ 15,021 total - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2026-04-22−2,941→ 0 totalExercise: $35.48From: 2019-12-20Exp: 2026-12-20→ Common Stock (2,941 underlying)
Footnotes (2)
- [F1]Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- [F2]This option is fully vested and exercisable.
Signature
/s/ Laurie A. Churchill, Attorney-in-fact|2026-04-23